EN IT

STOCKS

Reserved

Eli Lilly +6.6%: the buy signal reaches its second model reference

·42 min read
EXECUTIVE VIEW

Eli Lilly stock gains 6.6% as the buy signal, now in week 4, reaches the model's second reference. For a new entry, the indicated position size is reduced, and the next scaling-out window comes in week 6.

Reserved analysis Subscribe to read →
Reserved

Light +0.4%: the early-exit warning on the sell signal still stands

·41 min read
EXECUTIVE VIEW

Light stock edges up 0.4% in trading latinoamerica as the sell signal reaches week 3, with the short 9.64% in the red. Our model's early-exit warning still stands, and it advises against opening a new short.

Reserved analysis Subscribe to read →
Reserved

Li Auto -7.1%: short in week 10 under management, earnings due November 25

·41 min read
EXECUTIVE VIEW

Li Auto stock drops 7.1% and the sell signal, now in week 10, stays in its management phase with the short up 1.44%. Our model highlights the November 25 earnings report, which could trigger wide price swings either way.

Reserved analysis Subscribe to read →
Reserved

Leonardo +4.2%: sell signal in week 12, the short is still 5.24% in profit

·41 min read
EXECUTIVE VIEW

Leonardo stock gains 4.2%, yet the sell signal in week 12 keeps the short 5.24% in profit. Our model sees the trade in its management phase, and this week's rally does not change the overall picture for the position.

Reserved analysis Subscribe to read →
Reserved

Kyverna Therapeutics +3.5%: the managed short holds a 32.40% gain

·41 min read
EXECUTIVE VIEW

Kyverna Therapeutics stock rises 3.5%, while the sell signal, now in week 24, stays in its management phase. Our model shows the short still 32.40% in profit, and discipline suggests defending the gains built up so far.

Reserved analysis Subscribe to read →
Reserved

Eastman Kodak +1.5%: the sell signal moves into its management phase, short up 8.14%

·41 min read
EXECUTIVE VIEW

Eastman Kodak stock rises 1.5%, while the sell signal, now in week 5, moves into its management phase. The short is still 8.14% in profit, and our model suggests managing that gain with steady discipline.

Reserved analysis Subscribe to read →
Reserved

Coca-Cola +3.7%: the buy signal hits its first reference in week 4

·41 min read
EXECUTIVE VIEW

Coca-Cola stock gains 3.7% and the buy signal, now in week 4, reaches the model's first reference. For new entries our model indicates a standard position size, with the next scaling-out window coming in week 6.

Reserved analysis Subscribe to read →
Reserved

Kinder Morgan +6.5%: early-exit warning issued on the short position

·41 min read
EXECUTIVE VIEW

Kinder Morgan stock climbs 6.5%, and the sell signal, now in week 2, gets an early-exit warning. Our model suggests closing the short here, currently at a loss, and advises against opening new ones on this US stock.

Reserved analysis Subscribe to read →
Reserved

Klabin -0.9%: the sell signal is in its management phase, short up 3.35%

·41 min read
EXECUTIVE VIEW

Klabin stock slips 0.9%, a trading latinoamerica sell signal now in week 8 and in its management phase. Our model has the short 3.35% in profit and suggests that anyone already positioned keeps managing the trade with discipline.

Reserved analysis Subscribe to read →
Reserved

Kering -1.4%: the short in week 12 stands at +27.36%, trade under management

·41 min read
EXECUTIVE VIEW

Kering stock slips 1.4% and the sell signal, now in week 12, stays in its management phase with the short 27.36% in profit. Our model suggests handling the position with discipline to protect the gains built so far.

Reserved analysis Subscribe to read →
Reserved

Johnson & Johnson +3.5%: the buy signal holds, with a standard position size

·42 min read
EXECUTIVE VIEW

Johnson & Johnson stock gains 3.5% and the buy signal holds in week 2, 4.59% up since entry. Our model indicates a standard position size, with the next scaling-out window in week 6, for 10% of the position.

Reserved analysis Subscribe to read →
Reserved

JPMorgan Chase +3.5%: the rally tests the short, with the sell signal in week 8

·41 min read
EXECUTIVE VIEW

JPMorgan Chase stock rises 3.5% against the sell signal, now in week 8 and in its management phase. The short is down 0.91% since entry, and our model suggests staying disciplined in managing the trade, without letting the weekly bounce drive decisions.

Reserved analysis Subscribe to read →
Reserved

JD.com -4.1%: early-exit warning triggered in the buy signal's confirmation week

·42 min read
EXECUTIVE VIEW

JD.com stock drops 4.1% and the buy signal ends its confirmation week lower, triggering an early-exit warning. Our model suggests weighing an exit now, while the November 17 earnings report could bring wide swings in either direction.

Reserved analysis Subscribe to read →
Reserved

IXUS +2.2%: sell signal in its management phase, short still up 2.55%

·41 min read
EXECUTIVE VIEW

IXUS, the international stock ETF, gains 2.2% on the week, with its sell signal in week 6 and in the management phase. In our technical analysis, the short is still 2.55% in profit and the model favors disciplined handling of the position.

Reserved analysis Subscribe to read →
Share WhatsApp Telegram Gmail LinkedIn